UNIVERSAL VISION BIOTECHNOLOGY CO

The current price of 3218 is 246.5 TWD — it has decreased by 3.52% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange UNIVERSAL VISION BIOTECHNOLOGY CO stocks are traded under the ticker 3218.

UNIVERSAL VISION BIOTECHNOLOGY CO is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

3218 stock is 3.65% volatile and has beta coefficient of 0.27. Check out the list of the most volatile stocks — is UNIVERSAL VISION BIOTECHNOLOGY CO there?

One year price forecast for UNIVERSAL VISION BIOTECHNOLOGY CO has a max estimate of 350.0 TWD and a min estimate of 281.0 TWD.

3218 earnings for the last quarter are 3.14 TWD per share, whereas the estimation was 3.36 TWD resulting in a −6.43% surprise. The estimated earnings for the next quarter are 3.08 TWD per share. See more details about UNIVERSAL VISION BIOTECHNOLOGY CO earnings.

UNIVERSAL VISION BIOTECHNOLOGY CO revenue for the last quarter amounts to ‪1.06 B‬ TWD despite the estimated figure of ‪1.10 B‬ TWD. In the next quarter revenue is expected to reach ‪999.72 M‬ TWD.

Yes, you can track UNIVERSAL VISION BIOTECHNOLOGY CO financials in yearly and quarterly reports right on TradingView.

3218 net income for the last quarter is ‪253.14 M‬ TWD, while the quarter before that showed ‪266.18 M‬ TWD of net income which accounts for −4.90% change. Track more UNIVERSAL VISION BIOTECHNOLOGY CO financial stats to get the full picture.

Today UNIVERSAL VISION BIOTECHNOLOGY CO has the market capitalization of ‪21.65 B‬, it has decreased by 0.18% over the last week.

Yes, 3218 dividends are paid annually. The last dividend per share was 7.00 TWD. As of today, Dividend Yield (TTM)% is 2.22%. Tracking UNIVERSAL VISION BIOTECHNOLOGY CO dividends might help you take more informed decisions.

UNIVERSAL VISION BIOTECHNOLOGY CO dividend yield was 2.53% in 2023, and payout ratio reached 56.75%. The year before the numbers were 2.01% and 59.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 3218 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIVERSAL VISION BIOTECHNOLOGY CO stock right from TradingView charts — choose your broker and connect to your account.

3218 reached its all-time high on Apr 19, 2023 with the price of 432.0 TWD, and its all-time low was 16.0 TWD and was reached on Aug 25, 2015.
See other stocks reaching their highest and lowest prices.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNIVERSAL VISION BIOTECHNOLOGY CO technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNIVERSAL VISION BIOTECHNOLOGY CO stock shows the sell signal. See more of UNIVERSAL VISION BIOTECHNOLOGY CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on UNIVERSAL VISION BIOTECHNOLOGY CO future price: according to them, 3218 price has a max estimate of 350.00 TWD and a min estimate of 281.00 TWD. Read a more detailed UNIVERSAL VISION BIOTECHNOLOGY CO forecast: see what analysts think of UNIVERSAL VISION BIOTECHNOLOGY CO and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIVERSAL VISION BIOTECHNOLOGY CO EBITDA is ‪1.76 B‬ TWD, and current EBITDA margin is 43.06%. See more stats in UNIVERSAL VISION BIOTECHNOLOGY CO financial statements.